Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 23, 2015 10:04 AM ET

Pharmaceuticals

Company Overview of PanGenetics B.V.

Company Overview

PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases, cancer, and pain. The company develops a portfolio of antibody drugs through in-licensing model. Its products pipeline includes PG102-Prototype, an original chimeric anti-CD40 antibody; PG102, a CD40 antagonist; PG110, an anti-nerve growth factor antibody for use in chronic pain; PG130, an undisclosed therapeutic antibody; and PG140, an antagonist of CD86. The company was formerly known as Tanox Pharma B.V. The company was founded in 1995 and is based in Utrecht, the Netherlands with an additional office in Cambridge, the United Kingdom. PanGenetics B.V. is a former subsidiary of Tanox Inc.

Yalelaan 46

Utrecht,  3584CM

Netherlands

Founded in 1995

Phone:

31 30 253 7911

Fax:

31 30 253 3967

Key Executives for PanGenetics B.V.

PanGenetics B.V. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Farmaplein Europe
Farallone Therapeutics B.V. Europe
InPEC B.V. Europe
Boehringer Ingelheim B.V. Europe
BioClin B.V. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PanGenetics B.V., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.